ADGM
Price
$1.87Alerts
Change
+$0.03 (+1.63%)
Updated
Nov 11 closing price
Capitalization
1.44M
Earnings call today
Intraday BUY SELL Signals
INFU
Price
$15.04Alerts
Change
-$0.25 (-1.64%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
272.67M
126 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADGM vs INFU

ADGM vs INFU Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADGM vs. INFU commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADGM is a Hold and INFU is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ADGM with price predictions
Nov 10, 2026

ADGM's RSI Indicator sits in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for ADGM just turned positive on October 13, 2026. Looking at past instances where ADGM's MACD turned positive, the stock continued to rise in 19 of 19 cases over the following month. The odds of a continued upward trend are 90%.

Following a +3.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADGM advanced for three days, in 77 of 91 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

ADGM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ADGM as a result. In 38 of 39 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADGM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ADGM entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-3.473) is normal, around the industry mean (4.142). P/E Ratio (-0.047) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (60.976) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. ADGM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADGM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for INFU with price predictions
Nov 10, 2026

Aroon Indicator for INFU shows an upward move is likely

INFU's Aroon Indicator triggered a bullish signal on November 02, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 143 similar instances where the Aroon Indicator showed a similar pattern. In 104 of the 143 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on INFU as a result. In 79 of 116 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.

The Moving Average Convergence Divergence (MACD) for INFU just turned positive on November 10, 2026. Looking at past instances where INFU's MACD turned positive, the stock continued to rise in 43 of 64 cases over the following month. The odds of a continued upward trend are 67%.

INFU moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +11.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where INFU advanced for three days, in 175 of 264 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Bearish Trend Analysis

The 10-day RSI Indicator for INFU moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In 16 of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INFU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

INFU broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. INFU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.610) is normal, around the industry mean (4.142). P/E Ratio (32.595) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.180) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.817) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 86 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INFU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

FUNDAMENTALS RATINGS
INFU: Fundamental Ratings
INFU
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
56
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADGMINFU
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 9 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
73%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (ADGM: $1.84 vs. INFU: $15.28)
Brand notoriety: ADGM and INFU are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ADGM: 256% vs. INFU: 118%
Market capitalization -- ADGM: $1.44M vs. INFU: $272.67M
ADGM [@Medical/Nursing Services] is valued at $1.44M. INFU’s [@Medical/Nursing Services] market capitalization is $272.67M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADGM’s FA Score shows that 1 FA rating(s) are green while INFU’s FA Score has 0 green FA rating(s).

  • ADGM’s FA Score: 1 green, 4 red.
  • INFU’s FA Score: 0 green, 5 red.
According to our system of comparison, INFU is a better buy in the long-term than ADGM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADGM’s TA Score shows that 5 TA indicator(s) are bullish while INFU’s TA Score has 5 bullish TA indicator(s).

  • ADGM’s TA Score: 5 bullish, 3 bearish.
  • INFU’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ADGM is a better buy in the short-term than INFU.

Price Growth

ADGM (@Medical/Nursing Services) experienced а -28.85% price change this week, while INFU (@Medical/Nursing Services) price change was +19.37% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

Reported Earning Dates

ADGM is expected to report earnings on Nov 11, 2026.

INFU is expected to report earnings on Mar 17, 2027.

Industries' Descriptions

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

INFU and

Correlation & Price change

A.I.dvisor indicates that over the last year, INFU has been loosely correlated with AMIX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INFU jumps, then AMIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INFU
1D Price
Change %
INFU100%
+4.09%
AMIX - INFU
43%
Loosely correlated
+8.82%
VREX - INFU
42%
Loosely correlated
N/A
ICUI - INFU
39%
Loosely correlated
+1.82%
BFLY - INFU
36%
Loosely correlated
-2.40%
ANIK - INFU
33%
Loosely correlated
-7.55%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSM0.960.04
+3.94%
Sono Group NV
GLAD19.750.23
+1.18%
Gladstone Capital Corp
KYMR136.64-2.22
-1.60%
Kymera Therapeutics
NTRB5.76-0.20
-3.36%
Nutriband
IMNM18.65-0.71
-3.67%
Immunome